Wordt geladen...
Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis
BACKGROUND: Docetaxel, cisplatin, and 5-fluorouracil (DCF) therapy can cause severe adverse events, including neutropenia and febrile neutropenia. The feasibility of DCF therapy is a concern, particularly for elderly patients, patients with moderate organ disorders, and patients suffering from malnu...
Bewaard in:
| Gepubliceerd in: | World J Surg Oncol |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6027574/ https://ncbi.nlm.nih.gov/pubmed/29966526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-018-1420-8 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|